Italian Ambassador to Asharq Al-Awsat: Strategic Cooperation with Saudi Arabia is Growing in Light of Vision 2030

Italian Ambassador to Saudi Arabia Roberto Cantone (Asharq Al-Awsat)
Italian Ambassador to Saudi Arabia Roberto Cantone (Asharq Al-Awsat)
TT

Italian Ambassador to Asharq Al-Awsat: Strategic Cooperation with Saudi Arabia is Growing in Light of Vision 2030

Italian Ambassador to Saudi Arabia Roberto Cantone (Asharq Al-Awsat)
Italian Ambassador to Saudi Arabia Roberto Cantone (Asharq Al-Awsat)

Future Investment Initiative (FII7) established a new road map for cooperation between Rome and Riyadh and enhanced the opportunities for strategic and dynamic ties, said Italy’s Ambassador to Saudi Arabia Roberto Cantone.

Over 70 Italian companies are investing in the Saudi market, especially in green energy, artificial intelligence, and technology sectors.

In an interview with Asharq Al-Awsat, Cantone stressed that the FII7 became a leading global platform for exploring new trends, opportunities, challenges, and emerging industries that would shape the global economy and investment environment over the coming decades.

The FII7 Forum allowed Italian companies to discuss with their counterparts from investment groups and emerging companies in Riyadh.

According to Cantone, Italy’s high-level participation in the conference contributed to enriching discussions on pivotal long-term investment projects and global trends that shape future economies.

It also provided the opportunity to enhance cooperation between Rome and Riyadh in many areas, as identified by Vision 2030.

Cantone recalled that bilateral relations date back to the 1930s and have been expanded steadily over the years.

He indicated that the Kingdom currently witnesses steady growth in several areas of cooperation across various sectors, ranging between the latest technologies and their applications in the healthcare system, agriculture, space, cultural heritage, and preservation of antiquities.

Cantone reiterated that cooperation between Italy and the Kingdom is witnessing a strategic and dynamic development, as evident during the bilateral investment forum in Milan last September.

The forum highlighted the great potential to enhance cooperation between the two nations in various fields, including green energy, artificial intelligence, and technology, he said.

The latest trade exchange data shows bilateral trade relations between Italy and Saudi Arabia are witnessing upward growth, reaching $12 billion in 2022.

The first quarter of 2023 was also promising, as Italian exports to the Kingdom grew 24 percent.

The diplomat pointed out that Italian exports to the Kingdom include industrial machinery, electronic devices, communications devices, chemicals, pharmaceutical products, agricultural foods, fashion, design, cosmetics, and cars.

The total balance of Italian net foreign direct investment in Saudi Arabia amounted to more than $4.6 billion, said Cantone, pointing out that the investment forum in Milan witnessed the signing of a memorandum to enhance direct investments between the two countries.

Cantone concluded by expressing his pleasure that Saudi companies, namely the Public Investment Fund (PIF), have become more interested in investing in strategic sectors of the Italian economy, saying it confirms the Kingdom’s confidence in the Italian business environment.



Hevolution CEO Discusses Career in Innovation, Medicine, and Business

Dr. Mehmood Khan, CEO of the Hevolution Foundation
Dr. Mehmood Khan, CEO of the Hevolution Foundation
TT

Hevolution CEO Discusses Career in Innovation, Medicine, and Business

Dr. Mehmood Khan, CEO of the Hevolution Foundation
Dr. Mehmood Khan, CEO of the Hevolution Foundation

Dr. Mehmood Khan, CEO of the Hevolution Foundation, the largest philanthropy organization funding aging medicine in the world, expressed that receiving Saudi citizenship will boost his scientific and practical capabilities.
He said this new status will help him advance his research, especially in addressing aging.
This comes as part of a recent royal decree granting Saudi citizenship to several notable scholars, doctors, researchers, and innovators.
“Our Chairman, his Royal Highness (Crown Prince Mohammed bin Salman), has very high expectations of our work and the impact we need to do; We were created in part because of his vision,” Khan told Asharq Al-Awsat.
“Living up to the expectations and challenges we get faced with is itself exciting, but it is challenging,” revealed Khan, affirming that Hevolution’s team is “up to that task.”
Khan, who has experience in both corporate and medical fields, told Asharq Al-Awsat that his work across academic, public, and private sectors has been a continuous learning process, with each area enhancing the others.
According to the CEO, these industries are interconnected, and combining their strengths often leads to the best solutions.
This insight inspired the Hevolution initiative, which brings together the scientific community, NGOs, pharmaceutical companies, policymakers, academia, biotech firms, CEOs, and others to promote healthy aging.
Khan highlighted the value of integrating insights from different sectors.
Academia provides detailed research, the public sector offers insights on population health and regulations, and the corporate world brings innovation and efficiency, explained Khan, adding that by merging these perspectives, the world can tackle complex health challenges more effectively.
“We’ve been working through, and are now investing, funding and partnering with over 200 scientists around the world, and over 150 different university labs,” said Khan.
Hevolution uses this integrated approach to advance healthy aging.
This initiative embodies my passion for addressing major challenges and offers a significant opportunity to make a global impact.
Khan talked about the first $400 million commitment Hevolution made in the last 23 months, calling it “unprecedented.”
“There has never been a non-profit organization in the world that has gone from not existing to now becoming the largest philanthropy funding aging biology and medicine in the world,” affirmed Khan.
Khan stressed that work at Hevolution not only pushes scientific boundaries but also promotes cross-sector collaboration to improve global health outcomes.
Since Khan’s early days in medical school, he’s been deeply interested in nutrition and population health, which was an unconventional focus back then. This journey set the foundation for his later work in community health.
Khan’s time as an endocrinology faculty member at the Mayo Clinic was crucial. He led programs on diabetes, endocrine diseases, metabolism, and nutrition, which strengthened his expertise in designing disease prevention systems.
In the private sector, Khan took on a key role at Takeda Pharmaceutical as the global head of R&D, which shaped his approach to innovative healthcare solutions.
At PepsiCo, as Chief Scientific Officer, he learned crucial principles of scale, impact, transformation, and tackling global challenges.
As CEO of Hevolution, Khan uses all his professional experience to advance the foundation’s mission of developing health sciences to address age-related diseases.
Khan serves on the boards of Reckitt Benckiser and the Saudi Research, Development, and Innovation Authority (RDIA).
He is the CEO of Life Biosciences, a member of Saudi Arabia’s biotechnology strategy committee, and the chair of the advanced technology visiting committee at the US National Institute of Standards and Technology (NIST).
Khan told Asharq Al-Awsat that he feels honored to have recently become a Saudi citizen by royal decree, while also holding dual US and UK citizenship. This helps him lead Hevolution effectively and work closely with international partners.
Khan commented on his recent Saudi citizenship, saying that in addition to feeling honored to receive Saudi citizenship by royal decree, alongside other distinguished individuals, this recognition is a great privilege.
Being a Saudi citizen, as per Khan, is a significant milestone and acknowledges the progress in his work in aging science and global health. It also strengthens Khan’s commitment to the work at Hevolution.
Khan noted that this new status enhances his ability to build relationships and collaborate within the Kingdom and internationally. It offers a deeper connection with the local community and better opportunities to engage with policymakers and leaders.
He also said that this recognition boosts Hevolution’s global presence and credibility, making the foundation’s collaborations with international scientists and business leaders stronger. It positions Hevolution as a key player in addressing age-related diseases.
Khan emphasized that this honor reflects the hard work and innovation of Hevolution’s entire team.
The CEO said that it was collective efforts that have made this achievement possible.
Khan also said he is excited to engage more deeply with the scientific and medical community in the Kingdom, adding that his new citizenship helps him contribute to Vision 2030 and the national biotechnology strategy, promoting innovation and attracting top global talent.